Supplier of key reagents for drug development.

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Human CD300A, hFc-tag
Catalog Number NBL-240880
Alias/Synonyms CD300A; CMRF-35-H9; CMRF35-H9; CMRF35-H; IGSF12; IRp60; CLM-8; IRC1; IRC1/IRC2; IRC2; CD300a molecule; CD300a; CLM8; CMRF35HIRp60; LMIR1; MAIR-I; Mcipr1; NKRL; Pigr4
Appearance see COA
Molecule Weight Leu18-Pro180
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 Q9UGN4-1
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-240880-100ug 100ug Inquire Inquire
NBL-240880-1mg 1mg Inquire Inquire
NBL-240880-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human CD300A, hFc-tag


Catalog#:

NBL-240880


Description:

NebuSelect™ Recombinant Human CD300A, hFc-tag(Cat#NBL-240880) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu18-Pro180.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 44.4 kDa. Due to glycosylation, the protein migrates to 60-75 kDa based on Bis-Tris PAGE result.


Target Name:

CD300A; CMRF-35-H9; CMRF35-H9; CMRF35-H; IGSF12; IRp60; CLM-8; IRC1; IRC1/IRC2; IRC2; CD300a molecule; CD300a; CLM8; CMRF35HIRp60; LMIR1; MAIR-I; Mcipr1; NKRL; Pigr4


Target Information:

CD300a is an inhibitory receptor for mast cells and eosinophils in allergic inflammation (AI); however, the spatiotemporal expression of CD300a and its potential roles in the resolution of AI are still to be determined.CD300a expression on peritoneal cells is regulated from inflammation to resolution. CD300a activation on mouse bone marrow-derived mast cells regulated ALX/FPR2 expression levels following IgE-mediated activation.


Amino Acid Sequence: 

Leu18-Pro180


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items